WallStreetZenWallStreetZen

NASDAQ: EXAI
Exscientia PLC Stock

Open Broker Account
$4.96-0.04 (-0.8%)
Updated Dec 8, 2022
EXAI Price
$4.96
Fair Value Price
N/A
Market Cap
$608.46M
52 Week Low
$4.90
52 Week High
$24.99
P/E
-3.13x
P/B
1x
P/S
35.22x
PEG
N/A
Dividend Yield
N/A
Revenue
$29.23M
Earnings
-$115.96M
Gross Margin
-16.4%
Operating Margin
-468.55%
Profit Margin
-406.2%
Debt to Equity
0.32
Operating Cash Flow
-$32M
Beta
1.51
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

EXAI Overview

Exscientia plc is a pharmatech that offers end-to-end AI-enabled technologies for target identification, drug candidate design, translational models, and patient selection. Its platform enables the design of candidate drug molecules, as well as provides patients with drug therapies through AI-guided assessment. Exscientia was founded in 2012 and is headquartered in Oxford, UK.

Zen Score

Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how EXAI scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

EXAI is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
EXAI is good value based on its book value relative to its share price (1x), compared to the US Biotechnology industry average (4.98x)
P/B vs Industry Valuation
EXAI is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more EXAI due diligence checks available for Premium users.

Be the first to know about important EXAI news, forecast changes, insider trades & much more!

EXAI News

Valuation

EXAI price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-3.13x
Industry
13.31x
Market
21.39x

EXAI price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1x
Industry
4.98x
EXAI is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

EXAI's financial health

Profit margin

Revenue
$7.3M
Net Income
-$41.3M
Profit Margin
-563.3%
EXAI's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
EXAI's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$782.2M
Liabilities
$188.0M
Debt to equity
0.32
EXAI's short-term assets ($708.43M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
EXAI's short-term assets ($708.43M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
EXAI's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$76.2M
Investing
-$8.6M
Financing
-$455.8k
EXAI's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

EXAI vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
EXAI$608.46M-0.80%-3.13x1.00x
ICPT$608.83M+1.73%2.54x5.65x
VNDA$612.87M-0.09%83.31x1.19x
RNA$617.60M+8.62%-3.45x1.64x
MRUS$617.68M-2.41%-9.33x2.07x

Exscientia Stock FAQ

What is Exscientia's quote symbol?

NASDAQ: EXAI) Exscientia trades on the NASDAQ under the ticker symbol EXAI. Exscientia stock quotes can also be displayed as NASDAQ: EXAI.

If you're new to stock investing, here's how to buy Exscientia stock.

What is the 52 week high and low for Exscientia (NASDAQ: EXAI)?

(NASDAQ: EXAI) Exscientia's 52-week high was $24.99, and its 52-week low was $4.90. It is currently -80.15% from its 52-week high and 1.22% from its 52-week low.

How much is Exscientia stock worth today?

(NASDAQ: EXAI) Exscientia currently has 122,674,016 outstanding shares. With Exscientia stock trading at $4.96 per share, the total value of Exscientia stock (market capitalization) is $608.46M.

Exscientia stock was originally listed at a price of $27.10 in Oct 1, 2021. If you had invested in Exscientia stock at $27.10, your return over the last 1 years would have been -81.7%, for an annualized return of -81.7% (not including any dividends or dividend reinvestments).

How much is Exscientia's stock price per share?

(NASDAQ: EXAI) Exscientia stock price per share is $4.96 today (as of Dec 8, 2022).

What is Exscientia's Market Cap?

(NASDAQ: EXAI) Exscientia's market cap is $608.46M, as of Dec 10, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Exscientia's market cap is calculated by multiplying EXAI's current stock price of $4.96 by EXAI's total outstanding shares of 122,674,016.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.